BioCorRx Inc.
BICX
Brady Granier
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Brady Granier
BioCorRx Inc. reported in an 8-K filed April 3, 2024 that Brady Granier resigned as member of the board of directors, effective March 31, 2024. BioCorRx Inc. reported in an 8-K filed January 5, 2024 that Brady Granier resigned as Chief Executive Officer, effective January 31, 2024. BioCorRx Inc. reported in an 8-K filed January 5, 2024 that Brady Granier resigned as President, effective January 31, 2024.
“On March 29, 2024, Brady Granier submitted his letter of resignation from his position as a member of the board of directors (the "Board") of BioCorRx Inc. (the "Company"), effective March 31, 2024 (the "Granier Resignation").”
“On December 29, 2023, Brady Granier submitted his letter of resignation as President of BioCorRx Inc. (the “Company”) and Chief Executive Officer of BioCorRx Pharmaceuticals, a subsidiary of the Company, effective January 31, 2024 (the “Granier Resignation”).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
BioCorRx Inc. (BICX)
SEC 8-K
2020-11-09–2024-01-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.